Burney Co. lifted its holdings in shares of M.D.C. Holdings, Inc. (NYSE:MDC) by 20.9% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 292,442 shares of the construction company’s stock after purchasing an additional 50,604 shares during the period. Burney Co. owned about 0.52% of M.D.C. worth $8,998,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. Sorin Capital Management LLC purchased a new position in shares of M.D.C. during the 1st quarter worth approximately $1,726,000. Sun Life Financial INC purchased a new position in shares of M.D.C. during the 2nd quarter worth approximately $140,000. Schwab Charles Investment Management Inc. grew its stake in M.D.C. by 4.8% in the 1st quarter. Schwab Charles Investment Management Inc. now owns 343,862 shares of the construction company’s stock worth $9,601,000 after acquiring an additional 15,615 shares during the period. Baltimore Capital Management Inc. grew its stake in M.D.C. by 14.5% in the 2nd quarter. Baltimore Capital Management Inc. now owns 50,575 shares of the construction company’s stock worth $1,556,000 after acquiring an additional 6,400 shares during the period. Finally, LSV Asset Management grew its stake in M.D.C. by 49.8% in the 2nd quarter. LSV Asset Management now owns 2,220,833 shares of the construction company’s stock worth $68,335,000 after acquiring an additional 737,965 shares during the period. 78.14% of the stock is owned by institutional investors and hedge funds.

Several analysts have commented on the stock. Zacks Investment Research cut shares of M.D.C. from a “buy” rating to a “hold” rating in a research note on Saturday, August 25th. ValuEngine cut shares of M.D.C. from a “hold” rating to a “sell” rating in a research note on Tuesday, July 24th. Wedbush lowered their target price on shares of M.D.C. from $34.00 to $33.00 and set a “neutral” rating for the company in a research note on Thursday, August 2nd. JPMorgan Chase & Co. raised shares of M.D.C. from an “underweight” rating to a “neutral” rating and set a $36.00 target price for the company in a research note on Friday, July 13th. Finally, Raymond James reaffirmed a “buy” rating and issued a $39.00 target price (up from $35.00) on shares of M.D.C. in a research note on Tuesday, May 8th. One research analyst has rated the stock with a sell rating, five have given a hold rating and four have issued a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus target price of $36.14.

In other M.D.C. news, Chairman Larry A. Mizel sold 20,000 shares of M.D.C. stock in a transaction on Monday, August 27th. The shares were sold at an average price of $32.62, for a total value of $652,400.00. Following the transaction, the chairman now owns 131,867 shares in the company, valued at approximately $4,301,501.54. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Chairman Larry A. Mizel sold 10,000 shares of M.D.C. stock in a transaction on Wednesday, August 22nd. The shares were sold at an average price of $33.15, for a total transaction of $331,500.00. Following the completion of the transaction, the chairman now owns 121,867 shares in the company, valued at approximately $4,039,891.05. The disclosure for this sale can be found here. In the last quarter, insiders sold 50,000 shares of company stock worth $1,637,300. 27.00% of the stock is owned by company insiders.

MDC stock opened at $31.70 on Monday. The company has a market capitalization of $1.79 billion, a price-to-earnings ratio of 12.29, a PEG ratio of 0.46 and a beta of 1.44. The company has a debt-to-equity ratio of 0.72, a current ratio of 9.59 and a quick ratio of 2.49. M.D.C. Holdings, Inc. has a one year low of $26.45 and a one year high of $37.45.

M.D.C. (NYSE:MDC) last released its earnings results on Wednesday, August 1st. The construction company reported $1.12 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.85 by $0.27. The firm had revenue of $749.60 million during the quarter, compared to analysts’ expectations of $713.27 million. M.D.C. had a net margin of 6.91% and a return on equity of 13.82%. M.D.C.’s revenue for the quarter was up 15.5% on a year-over-year basis. During the same period in the previous year, the company earned $0.64 EPS. sell-side analysts expect that M.D.C. Holdings, Inc. will post 3.79 EPS for the current year.

The business also recently declared a quarterly dividend, which was paid on Wednesday, August 22nd. Shareholders of record on Wednesday, August 8th were issued a $0.30 dividend. The ex-dividend date of this dividend was Tuesday, August 7th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 3.79%. M.D.C.’s dividend payout ratio (DPR) is presently 46.51%.

About M.D.C.

M.DC Holdings, Inc, through its subsidiaries, engages in the homebuilding and financial service businesses. Its homebuilding operations include purchasing finished lots or developing lots for the construction and sale primarily of single-family detached homes to first-time and first-time move-up homebuyers under the Richmond American Homes name.

Featured Story: What is the NASDAQ Stock Market?

Want to see what other hedge funds are holding MDC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for M.D.C. Holdings, Inc. (NYSE:MDC).

Institutional Ownership by Quarter for M.D.C. (NYSE:MDC)

Receive News & Ratings for M.D.C. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for M.D.C. and related companies with MarketBeat.com's FREE daily email newsletter.